News by subject: TRI

Akeso, Inc. (9926.HK) ("Akeso," "we," or the "Company") today announced that the Company presented the promising phase II results of cadonilimab (a tetravalent PD-1/CTLA-4 bispecific antibody) and Lenvatinib (Len) combined with TACE for the treatment...

Health Canada has authorized Jardiance® (empagliflozin) to reduce the risk of sustained eGFR decline, end-stage kidney disease and cardiovascular and renal death in adults with chronic kidney disease (CKD),1 Boehringer Ingelheim (Canada) Ltd. and Eli...

Biomica Ltd., a clinical-stage biopharmaceutical company developing innovative microbiome-based therapeutics and a subsidiary of Evogene Ltd. , announced its CEO, Dr. Elran Haber, will participate in the 8th Annual Microbiome Movement Drug...

Caris Life Sciences®(Caris), the leading next-generation AI TechBio company and precision medicine pioneer that is actively developing and delivering innovative solutions to revolutionize healthcare and improve the human condition using molecular...

New paper in The Lancet Neurology proposes the first iteration of a research framework for defining and staging Parkinson's disease (PD) based on biology, rather than clinical symptomsThe framework defines PD based on the neuronal alpha-synuclein...

Caliway Biopharmaceuticals (Caliway) announces that Australian Bellberry HREC has approved Caliway's application to initiate CBL-514's Pivotal Phase 3 study (CBL-0301 Phase 3) for subcutaneous fat reduction. "We are all delighted to see CBL-514...

Denifanstat achieved statistically significant results on primary and multiple secondary endpoints in a 52-week clinical trial of 168 NASH patients with stage 2 or 3 fibrosis -  Primary efficacy endpoints: NASH resolution without worsening of...

In another milestone since the implementation of CAR-T therapy at Jiahui, the first myeloma patient treated with CAR-T at Jiahui International Hospital was recently discharged two weeks after infusion. The foreign patient was first diagnosed with...

Bold Therapeutics, a clinical-stage biopharmaceutical company developing novel metallotherapeutics, presented positive Phase 2 safety and efficacy data in advanced metastatic colorectal cancer (mCRC) patients treated with BOLD-100 in combination with...

Haystack Oncology, a Quest Diagnostics company and developer of best-in-class personalized MRD technology (Haystack MRDtm), has entered a research collaboration with TriSalus Life Sciences to evaluate therapeutic response and provide molecular...

ProofPilot , the leading platform for clinical trial automation & guidance, today announced its "Protocol Bowl" event at the 15th Annual SCOPE Summit for clinical trial operations executives the day after Sunday's Big Game. The "Protocol Bowl" will...

Seelos Therapeutics, Inc. ("Seelos"), a clinical-stage biopharmaceutical company focused on the development of therapies for central nervous system disorders and rare diseases, today announced the receipt of minutes from its End of Phase...

Data illustrates rapid and significant clearance in moderate to severe scalp psoriasis and significant improvement in scalp itch, as well as patient-reported health-related quality of life outcomes, including post-inflammatory pigmentation at 16...

INOVIO , a biotechnology company focused on developing and commercializing DNA medicines to help treat and protect people from HPV-associated diseases, cancer and infectious diseases, today announced that it will participate in a virtual fireside...

Meru Health, a technology-enabled digital mental health provider with a novel mind-body approach to mental healthcare, published a randomized controlled trial in collaboration with Stanford University, Harvard University, and University of Louisville...

On January 17, 2024, NK CellTech Co., Ltd. (NK CellTech), a leading biotech company focused on the development of NK cellular therapies, is pleased to announce that the FDA has granted clearance for the clinical trial of NK010, the non-genetically...

Ionis Pharmaceuticals, Inc.  today announced positive topline results for...

Mallinckrodt plc, a global specialty pharmaceutical company, today announced the presentation of findings from a post hoc analysis of the Phase 3 CONFIRM clinical trial. In this analysis, treatment with TERLIVAZ® (terlipressin) for injection was...

NRx Pharmaceuticals, Inc. ("NRx Pharmaceuticals", the "Company"), a clinical-stage biopharmaceutical company, today announced completion of enrollment in its Phase 2b/3 study of NRX-101, the...

Octapharma announced today the publication of the results from the clinical study WIL-31, which investigated the efficacy and safety of...

Jacobio Pharmaceuticals (1167.HK), a clinical-stage oncology company focusing on undruggable targets, announced data of glecirasib in patients with pancreatic cancer and other solid tumors in the oral abstract session at the American Society of...

Johnson & Johnson...

Tampa General Hospital (TGH) announced that the TGH Cancer Institute recently completed Florida's first successful infusion of Hemgenix, a gene therapy option for patients with severe hemophilia B ? a rare bleeding disorder characterized by failure...

CARsgen Therapeutics Holdings Limited (Stock Code: 2171.HK), a company focused on innovative CAR T-cell therapies for the treatment of hematologic malignancies and solid tumors, announces that at the 2024 American Society of Clinical Oncology...

Tissue engineering, which involves the use of grafts or scaffolds to aid cell regeneration, is emerging as a key medical practice for treating volumetric muscle loss (VML), a condition where a significant amount of muscle tissue is lost beyond the...

Kyverna Therapeutics, Inc. (Kyverna), a patient-centered clinical-stage biopharmaceutical company focused on developing cell therapies for patients suffering from autoimmune diseases, today announced it...

Endo International plc announced today that two new presentations related to Dupuytren's contracture and XIAFLEX® (collagenase clostridium histolyticum) were shared during the American Association for Hand Surgery (AAHS) annual meeting. Endo...

Michael E. DeBakey VA Medical Center announces opening of a new clinical trial using CK0803- off-the-shelf, allogeneic T regulatory cells that have been modified to target neuroinflammation to treat the fatal neurodegenerative disease ? Amyotrophic...

Eiger BioPharmaceuticals, Inc. , a commercial-stage biopharmaceutical company focused on the development of innovative therapies for...

The University of Colorado Anschutz Medical Campus announced the grant awards for the Anschutz Acceleration Initiative, a program focused on advancing cutting-edge healthcare innovations poised to reach patients within three to five years. The...

InSpan, a...

An exhalation delivery system with fluticasone (EDS-FLU) may reduce symptoms of chronic rhinosinusitis and improve patient's quality of life according to new research from The...

The Board of Pharmacy Specialties® (BPS), the post-licensure certification organization serving the pharmacy profession, issues a call for petition in pharmacy informatics.  In January 2024, the BPS Board of Directors reviewed a job analysis (JA;...

Helio Genomics, an AI-driven healthcare company specializing in diagnostics technology and test development for cancer detection, today announced that results from an important new research study have been published in the peer-reviewed journal,...

A game-changing clinical trial has revealed that enhancing the already renowned Mediterranean diet with pure C15:0 supplementation can elevate health outcomes even further. C15:0 (also called pentadecanoic acid) is the first essential fatty acid to...

Abbott's Volttm Pulsed Field Ablation System is designed to provide a new therapy option for people battling heart rhythm disorders such as atrial fibrillationPulsed field ablation ? or PFA ? uses high energy electrical pulses for ablation procedures...

Plantar fasciitis (PF) is a common musculoskeletal, inflammatory condition, characterized by severe pain in the heel of the foot, to the extent that it limits day-to-day activities. The plantar fascia ligament, a fibrous connecting tissue, supports...

Discover a groundbreaking webinar delving into the statistical data strategies and considerations of ophthalmology clinical trials, as well as supporting...

Hoth Therapeutics, Inc. , a patient-focused biopharmaceutical company, announced today that it has received U.S. Food and Drug Administration (FDA) clearance to implement a number of protocol amendments to its ongoing clinical trial for HT-001, which...

Eisai announced today the presentation of research in renal cell carcinoma (RCC) during the 2024 American Society of Clinical Oncology (ASCO) Genitourinary Cancers Symposium (#GU24)...

NeuroBo Pharmaceuticals, Inc. , a clinical-stage biotechnology company focused on transforming cardiometabolic diseases, today announced positive pre-clinical safety data of DA-1241, a novel G-Protein-Coupled Receptor 119 (GPR119) agonist, in...

Evommune, Inc., a clinical stage biotechnology company discovering and developing new ways to treat immune-mediated inflammatory diseases, today announced the initiation of its Phase 1 first-in-human study, evaluating EVO756 in heathy adults and...

Nanoscope Therapeutics Inc., a late-stage clinical biotechnology company developing gene therapies for...

PureIMS, a pharmaceutical company focused on the development of innovative inhalation products, this week reported it has completed a comparative pharmacokinetic study with Levodopa Cyclops®. The study results show rapid pulmonary absorption of...

Golden Biotechnology Corp. (TPEX 4132) ("GoldenBiotech", GBC), an advanced biopharmaceutical drug development company, had unveiled the findings of its Phase II clinical trial investigating Antroquinonol (HOCENA) in combination with the standard of...

Synendos Therapeutics AG (Synendos), a world leader in innovative Endocannabinoid System (ECS) treatments,...

PeproMene Bio, Inc., a clinical-stage biotech company developing novel therapies to treat cancers and immune disorders, today announced that the cohort 1 first patient treated in its Phase 1 relapsed or refractory B-cell acute lymphoblastic leukemia...

Amplia Therapeutics Limited , ("Amplia" or the "Company"), is pleased to announce that the US FDA have cleared Amplia's IND application for a trial of Amplia's best-in-class...

Vanda Pharmaceuticals Inc. (Vanda) today announced the publication of an article titled "Efficacy and Safety of Iloperidone in Bipolar Mania: A Double-Blind, Placebo-Controlled Study" in the Journal of Clinical Psychiatry.1 The findings of this...

Showcasing wilate® at EAHAD 2024 WIL-31 is the largest...